IMI2-2014-02-01
IMI2-2014-02-01
3 projects · €85,014,965 total EU contribution (project-level) · 22 participating organizations · 11 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€85,014,965
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (5)
- Italy (3)
- UK (3)
- CH (2)
- Netherlands (2)
- US (2)
- BF (1)
- Germany (1)
- GA (1)
- SE (1)
- SL (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- UOXF3 projects · UK
- CHU Bordeaux2 projects · FR
- INSERM2 projects · FR
- Janssen Vaccines (f.k.a. Crucell Holland B.V.)2 projects · NL
- LSHTM2 projects · UK
- UBx2 projects · FR
- Leiden University Medical Center1 projects · NL
- NEWLINK GENETICS CORP1 projects · US
- CERMEL1 projects · GA
- CM1 projects · BF
- DH1 projects · UK
- UT1 projects · DE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 EBOVAC2 · 115861 | H2020 | €22,790,820 | €2,041,083 | Details |
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854 EBOVAC1 · 115854 | H2020 | €58,336,885 | €9,097,864 | Details |
Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842 VSV-EBOVAC · 115842 | H2020 | €3,887,260 | €62,500 | Details |